CRDF vs NVR · rev $145.0K vs P/E 15, rev $4.21B
Cardiff Oncology Inc (CRDF) versus NVR Inc (NVR) — a side-by-side from cached financials, not a winner call.
Cardiff Oncology Inc (CRDF) is a biotechnology company listed on US.
NVR Inc (NVR) is a residential construction company listed on NYSE.
Latest reported CRDF revenue for 2026-06-30 was $145.0K. Net income was -$21.6M. CRDF currently screens at market cap $238.8M.
Latest reported NVR revenue for 2026-06-30 was $4.21B. Net income was $434.8M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
CRDF currently screens at market cap $238.8M. NVR currently screens at market cap $16.94B and trailing P/E 15.3.
Not investment advice. Open the CRDF and NVR stock pages for the full models.
Not investment advice.